Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $732.4300 (-1.88%) ($732.4300 - $748.7800) on Thu. Dec. 15, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.67% (three month average) | RSI | 51 | Latest Price | $732.4300(-1.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.9% a day on average for past five trading days. | Weekly Trend | REGN declines -0.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) DIA(33%) IWD(29%) SPLV(29%) SDY(28%) | Factors Impacting REGN price | REGN will decline at least -0.835% in a week (0% probabilities). TBT(-14%) URA(-5%) ARKG(-4%) VCSH(-3%) ARKK(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.835% (StdDev 1.67%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $747.71 | 5 Day Moving Average | $744.94(-1.68%) | 10 Day Moving Average | $752.02(-2.6%) | 20 Day Moving Average | $747.71(-2.04%) | To recent high | -4.4% | To recent low | 7% | Market Cap | $77.659b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |